European Journal of Gynaecological Oncology,2025,46(4):64-72 DOI:10.22514/ejgo.2025.052
Original Research
A new prediction model of triple-negative breast cancer based on ultrasound radiomics
Dan Li1, Qinghong Duan1,2,*,

1School of Medical Imaging, Guizhou Medical University, 550004 Guiyang, Guizhou, China

2Department of Medical Imaging, the Affiliated Cancer Hospital of Guizhou Medical University, 550008 Guiyang, Guizhou, China

*Corresponding Author(s):duanqinghong@gmc.edu.cn (Qinghong Duan)

History Submitted: 18 October 2023 | Accepted: 01 December 2023 | Published: 15 April 2025
Copyright:  ©2025  The Author(s). Published by MRE Press.
This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).

Collapse table of contents

Abstract

Background: This study aims to assess the diagnostic potential of a radiomics model based on ultrasonic imaging and characteristics for triple-negative breast cancer (TNBC). Methods: We retrospectively assessed the data of 127 patients with breast tumors, dividing them into training (n = 88) and testing (n = 39) sets. Four machine learning (ML) algorithms were employed, and we compared three distinct prediction models. Accuracy, sensitivity, specificity and the area under the receiver operating characteristic curve (AUC) served as the metrics for evaluating the predictive capacity of these models for TNBC. Results: Multivariate logistic regression analysis identified margin (odds ratio (OR) 0.296; 95% confidence interval (CI) 0.127–0.692; p = 0.005) and posterior echo (OR 0.323; 95% CI 0.112–0.930; p = 0.036) as independent TNBC predictors. We selected thirteen key image features to construct an ultrasonic imaging radiomics model. In the ultrasonic imaging radiomics model, the AUC values for logistic regression (LR), support vector machine (SVM), decision tree (DT), and random forest (RF) were 0.78, 0.80, 0.84 and 0.95 for the training set, and 0.68, 0.55, 0.71 and 0.65 for the testing set, respectively. In the ultrasonic feature model, the AUC values for LR, SVM, DT and RF were 0.73, 0.54, 0.73 and 0.73 for the training set, and 0.58, 0.82, 0.59 and 0.60 for the testing set, respectively. In the comprehensive model, which combines ultrasonic feature and radiomics feature models, the AUC values for LR, SVM, DT and RF were 0.85, 0.92, 0.78 and 0.92 for the training set, and 0.64, 0.69, 0.63 and 0.76 for the testing set, respectively. Conclusions: Compared with ultrasonic feature and radiomics feature models, the comprehensive model demonstrated better diagnostic performance and could identify TNBC more effectively.

Keywords:Radiomics;Triple-negative breast cancer (TNBC);Ultrasound;Prediction mode;Machine learning
PDF(10.61 MB)|EndNote (RIS)|BibTeX|RefMan|RefWorks

Cite this article

Dan Li, Qinghong Duan. A new prediction model of triple-negative breast cancer based on ultrasound radiomics.European Journal of Gynaecological Oncology,2025,46(4):64-72 DOI:10.22514/ejgo.2025.052

1. Introduction

Female breast cancer has surpassed lung cancer as the leading cause of cancer incidence worldwide [1]. Breast cancer is classified into four distinct molecular subtypes: luminal A, luminal B, human epidermal growth factor receptor 2 (HER2)-positive, and triple-negative breast cancer (TNBC) [2]. TNBC is characterized by the absence of estrogen receptor, progesterone receptor and HER2 expression. Unlike other molecular subtypes of breast cancer, TNBC is associated with a poor prognosis and a more aggressive clinical course [3, 4]. Therefore, the accurate diagnosis of TNBC prior to initiating treatment is of significant importance in clinical practice to improve treatment outcomes.

Currently, core needle biopsy (CNB) is the established method for diagnosing breast lesions of indeterminate or malignant nature [5]. However, both core needle biopsy and surgical procedures possess inherent limitations, such as invasiveness and potential for procedural failure. In cases involving breast reduction, there is also a risk of associated complications. Breast ultrasound (US) is the standard diagnostic modality for patients with breast tumors. Lesions are assessed based on their size, shape, texture, and other defining characteristics [6]. Radiomics, involving the extraction of extensive image features, subsequent feature screening and classification, holds significant promise in predicting the molecular subtype of various tumors [7]. Therefore, US-based radiomics holds promising potential for achieving an accurate diagnosis of TNBC before treatment initiation.

In recent years, machine learning (ML) has gained significant recognition, particularly in the field of medicine, due to its ability to effectively process extensive datasets [8]. The elucidation of model decisions is important in enhancing the significance of predictions, extracting vital information from machine learning models and enhancing the reliability and confidence in the outcomes of breast cancer molecular subtype studies. Among the ML algorithms utilized in these studies are decision tree (DT), logistic regression (LR), random forest (RF), support vector machine (SVM), and others [9, 10].

In this study, we developed three distinct prediction models: an ultrasonic feature model, a radiomics feature model, and a comprehensive model that amalgamated ultrasonic and radiomics features. Four machine learning (ML) algorithms, namely LR, SVM, DT and RF, were used to investigate the diagnostic potential of US radiomics in these differential diagnosis models. Overall, the results indicated that the TNBC prediction model based on US radiomics not only increases the diagnostic abilities of radiologists but also serves as a valuable tool for clinicians in TNBC diagnosis, thereby facilitating the formulation of treatment strategies.

2. Materials and methods

2.1 Subjects

We retrieved the data of 127 patients with breast cancer, confirmed through pathology, at the Affiliated Tumor Hospital of Guizhou Medical University between 2020 and 2022. The study inclusion criteria encompassed: (1) Female with breast masses suspected through US; (2) Availability of complete clinical data; (3) Underwent breast surgery and had comprehensive immunohistochemical data. The exclusion criteria were: (1) Underwent preoperative therapy; (2) Had multifocal lesions or bilateral disease; (3) Cases involving benign breast lesions or carcinoma in situ; (4) Missing important histopathological findings that would affect data analysis; (5) Insufficient information or incomplete imaging records. Verbal informed consent was obtained from all patients for the use of their data.

2.2 Ultrasonography

The US examination was conducted 1–2 weeks before surgery using an ultrasound scanner equipped with a linear array probe operating at a frequency range of 4–15 MHz. Briefly, the patient assumed a supine position on the examination bed, with arms raised above the head, ensuring full exposure of both breasts and the axillary region. An experienced sonographer systematically scanned all quadrants of the breast, including the nipple, areola, and bilateral axilla, to ensure a comprehensive scanning range without any omissions. In cases where a positive lesion was identified, the lesion area underwent multi-angle and multi-section scanning. The US images capturing the long axis of the mass were acquired and stored in BMP format.

During the examination, we carefully observed and documented various US features of the lesions, including boundary clarity (categorized as clear, still clear or unclear), shape (classified as regular for round and oval shapes and irregular for all others), edge smoothness (categorized as smooth or unsmooth, with unsmooth referring to the presence of microlobulation, angulation or spiculation at the lesion’s edge), lymph node metastasis (noted as yes, no or unclear), blood flow grade (graded as Ⅰ, Ⅱ, Ⅲ or Ⅳ), orientation (described as parallel or vertical), presence of a hyperechoic halo (indicated as yes or no), posterior echo characteristics (categorized as no change, enhancement or attenuation), and the presence or absence of calcification.

2.3 Segmentation of lesions

Accurate object segmentation in medical images is a critical step in medical diagnosis and various applications. However, despite extensive research on automatic segmentation methods, achieving clinically acceptable image quality remains a challenging task [11]. Herein, experienced US imaging diagnostic physicians utilized the ITK-SNAP software (http://www.itksnap.org/pmwiki/pmwiki.php) for manual segmentation. To ensure precision, we opted for manual segmentation, which involved outlining along the tumor boundary and encompassing the entire tumor lesion. To guarantee the robustness and reproducibility of subsequent US image features, another physician skilled in ultrasonographic breast diagnosis was invited to participate. Both physicians were kept unaware of the clinical information and pathology results pertaining to the patients. The region of interest (ROI) for the lesion was meticulously delineated (Fig. 1).

Delineation of the region of interest on breast cancer 
ultrasound images. (A,B) The image of a 45 year old female with 
non-triple-negative breast cancer; (C,D) The images of a 58 year old female with 
triple negative breast cancer. (A) and (C) show the original images, and (B) and 
(D) show the segmented images.

Fig. 1.Delineation of the region of interest on breast cancer ultrasound images. (A,B) The image of a 45 year old female with non-triple-negative breast cancer; (C,D) The images of a 58 year old female with triple negative breast cancer. (A) and (C) show the original images, and (B) and (D) show the segmented images.

2.4 Radiomics features

In this study, we employed the open-source tool PyRadiomics 3.0 [12] for extracting US radiomics features, including: (1) first-order features; (2) three-dimensional (3D) shape features; (3) two-dimensional (2D) shape features; (4) grey-level co-occurrence matrix (GLCM) features; (5) grey-level run length matrix (GLRLM) features; (6) grey-level size zone matrix (GLSZM) features; (7) neighboring grey-tone difference matrix (NGTDM) features; and (8) grey-level dependence matrix (GLDM) features.

2.5 Feature selection

The patient data were divided into training and testing sets based on the chronological order of their examinations. The training set was used for feature screening and model construction, while the testing set was used to validate the model’s performance. The feature selection process consisted of three steps: first, a feature repeatability test, where radiomics features extracted from ROI delineated by two experienced diagnostic physicians were assessed for agreement using the intraclass correlation coefficient (ICC), categorizing reproducibility as poor (ICC <0.40), fair to good (ICC = 0.40–0.75), or excellent (ICC >0.75); second, univariate and multivariate analyses were conducted to identify independent predictors of TNBC, and; third, radiomics feature screening was performed using the RF selection algorithm.

2.6 Model construction and evaluation

In this study, we employed four ML algorithms, LR, SVM, DT and RF, to establish three distinct prediction models. These models included an ultrasonic feature model, a radiomics feature model, and a comprehensive model that integrated both ultrasonic and radiomics features. Briefly, LR is a multiple regression technique utilized for analyzing the relationship between binary or classification outcomes and multiple influencing factors [13]. Comparatively, SVM is a versatile supervised learning model that is applied to classify and regress data [13], DT represents a straightforward and intuitive machine learning approach that introduces sequential nonlinearity of variables [14], and RF is an integrated model that can construct multiple random decision trees using bagging methods [15]. The performance of the three models in predicting TNBC was assessed using metrics such as accuracy, sensitivity, specificity, and the area under the curve (AUC). The complete data analysis process is shown in Fig. 2.

Flowchart of the radiomics process and analysis.

Fig. 2.Flowchart of the radiomics process and analysis.

2.7 Statistical analysis

The analysis of breast tumor US features and statistical procedures was conducted using the Python 3.10 statistical software (https://www.python.org) and packages, such as pandas, numpy, sklearn.metrics and matplotlib.pyplot as the primary tools for data analysis and figure plotting. Quantitative data are presented as mean values with corresponding standard deviations, while categorical variables are presented as percentages (n %). Differences among categorical variables were assessed via Chi-square tests, and features demonstrating significance in the univariate analysis were subsequently integrated into the multivariate Logistic Regression (LR) model. A significance level of p < 0.05 is considered statistically significant.

3. Results

3.1 Demographics

The study comprised a total of 127 patients with breast tumors. Among them, 39 patients had TNBC, with an average age of 51.18 ± 10.72 years, while 88 patients had non-TNBC, with an average age of 48.86 ± 8.88 years. These 127 breast lesions were randomly divided into two groups: a training set (n = 88; average age of 49.70 ± 9.92 years) and a testing set (n = 39; average age of 49.28 ± 8.58 years). Their additional basic data is shown in Supplementary Table 1.

3.2 Consistency check

Consistency check analysis indicated that the two senior US diagnostic physicians demonstrated excellent agreement in feature assessments, as indicated by high intraclass correlation coefficients (ICC = 0.78–0.99; p < 0.001) (Supplementary Table 2).

3.3 Univariate and multivariate analysis of US features of breast tumors

To identify independent predictors for TNBC, we conducted univariate analysis on the US features of the breast masses. The results revealed significant differences in terms of tumor boundary and posterior echo in the training set (p < 0.05), which were included in the multivariate LR analysis. The results revealed that both the tumor margin (OR 0.296; 95% CI 0.127–0.692; p = 0.005) and posterior echo (OR 0.323; 95% CI 0.112–0.930; p = 0.036) were independent influencing factors for predicting TNBC (Table 1 and Supplementary Table 3).

Table 1.Multivariate logistic regression analysis of ultrasound features in the training set.
FeatureOR95% CIp
Boundary0.2960.127–0.6920.005
Posterior echo0.3230.112–0.9300.036
OR: odds ratio; CI: confidence interval.

3.4 Radiomics feature extraction and screening

The PyRadiomics software was used to extract US image features from the ROIs. Each image yielded a total of 105 radiomics features, encompassing first-order features (18), shape features (12), GLCM features (24), GLSZM features (16), GLRLM features (16), GLDM features (14), and NGTDM features (5). Due to variations in the calculation methods for each feature and the differing magnitudes of feature values across dimensions, the Z-score method was used for standardization.

The RF method was used for feature screening, resulting in the selection of 14 radiomics features that exhibited the highest relevance to breast tumor classification. These selected features comprised 2 first-order features, 6 shape features and 6 texture features, which included 1 from GLSZM, 2 from GLRLM, and 3 from NGTDM (Supplementary Table 4).

3.5 Prediction model through LR

After the above screening of radiomics and US features, these selected features were integrated into the ML model for model construction and subsequent prediction. The ROC curves for the LR-based ML models, which include the US feature model, radiomics feature model and comprehensive model, are shown in Fig. 3. In the training set, the AUC values were 0.73 (0.62, 0.74), 0.78 (0.75, 0.89) and 0.85 (0.79, 0.90), respectively, while in the testing set, the AUC values were 0.58 (0.50, 0.79), 0.68 (0.54, 0.84) and 0.64 (0.56, 0.86), respectively. Additional details regarding accuracy, specificity and sensitivity are shown in Table 2.

ROC curves of each prediction model based on the LR algorithm. (A) training set; (B) testing set.

Fig. 3.ROC curves of each prediction model based on the LR algorithm. (A) training set; (B) testing set.

Table 2.Diagnostic performance of each prediction model based on LR machine learning algorithm.
Training setTesting set
Accuracy (%)Sensitivity (%)Specificity (%)AUCAccuracy (%)Sensitivity (%)Specificity (%)AUC
Ultrasound feature model0.72 (0.70, 0.81)0.29 (0.17, 0.46)0.95 (0.91, 0.97)0.73 (0.62, 0.74)0.82 (0.62, 0.85)0.50 (0.08, 0.52)0.90 (0.83, 1.00)0.58 (0.50, 0.79)
Radiomics feature model0.78 (0.73, 0.85)0.55 (0.30, 0.63)0.91 (0.90, 0.97)0.78 (0.75, 0.89)0.72 (0.59, 0.82)0.25 (0.07, 0.62)0.84 (0.73, 1.00)0.68 (0.54, 0.84)
Comprehen-sive model0.75 (0.74, 0.85)0.55 (0.33, 0.65)0.86 (0.87, 0.97)0.85 (0.79, 0.90)0.77 (0.58, 0.85)0.38 (0.07, 0.63)0.87 (0.70, 1.00)0.64 (0.56, 0.86)
95% confidence intervals are included in brackets. AUC: area under the receiver operating characteristic curve.

3.6 Prediction model through SVM

The ROC curves for the SVM-based ML models, including the US feature model, image feature model and comprehensive model, are presented in Fig. 4. In the training set, the AUC values were 0.54 (0.56, 0.77), 0.80 (0.76, 0.93) and 0.92 (0.87, 0.96), respectively, and in the testing set, they were 0.82 (0.41, 0.83), 0.55 (0.47, 0.78) and 0.69 (0.52, 0.80), respectively. Further details regarding accuracy, specificity and sensitivity are shown in Table 3.

ROC curves of each prediction model based on the SVM algorithm. (A) training set; (B) testing set.

Fig. 4.ROC curves of each prediction model based on the SVM algorithm. (A) training set; (B) testing set.

Table 3.Diagnostic performance of each prediction model based on SVM machine learning algorithm.
Training setTesting set
Accuracy (%)Sensitivity (%)Specificity (%)AUCAccuracy (%)Sensitivity (%)Specificity (%)AUC
Ultrasound feature model0.73 (0.73, 0.82)0.32 (0.25, 0.49)0.95 (0.90, 0.98)0.54 (0.56, 0.77)0.85 (0.63, 0.85)0.62 (0.09, 0.63)0.90 (0.82, 1.00)0.82 (0.41, 0.83)
Radiomics feature model0.77 (0.75, 0.85)0.45 (0.19, 0.61)0.95 (0.92, 1.00)0.80 (0.76, 0.93)0.77 (0.56, 0.78)0.12 (0.00, 0.45)0.94 (0.77, 1.00)0.55 (0.47, 0.78)
Comprehen-sive model0.82 (0.76, 0.86)0.48 (0.20, 0.61)1.00 (0.95, 1.00)0.92 (0.87, 0.96)0.79 (0.55, 0.81)0.12 (0.00, 0.44)0.97 (0.80, 1.00)0.69 (0.52, 0.80)
95% confidence intervals are included in brackets. AUC: area under the receiver operating characteristic curve.

3.7 Prediction model through DT

The ROC curves for DT-based ML models, including the US feature model, image feature model and comprehensive model, are illustrated in Fig. 5. In the training set, the AUC values were 0.73 (0.64, 0.77), 0.84 (0.69, 0.88) and 0.78 (0.70, 0.83), respectively, while in the testing set, they were 0.59 (0.52, 0.75), 0.71 (0.43, 0.78) and 0.63 (0.42, 0.73), respectively. Further details regarding accuracy, specificity and sensitivity are shown in Table 4.

ROC curves of each prediction model based on the DT algorithm. (A) training set; (B) testing set.

Fig. 5.ROC curves of each prediction model based on the DT algorithm. (A) training set; (B) testing set.

Table 4.Diagnostic performance of each prediction model based on DT machine learning algorithm.
Training setTesting set
Accuracy (%)Sensitivity (%)Specificity (%)AUCAccuracy (%)Sensitivity (%)Specificity (%)AUC
Ultrasound feature model0.73 (0.72, 0.82)0.32 (0.21, 0.49)0.95 (0.90, 0.98)0.73 (0.64, 0.77)0.82 (0.62, 0.83)0.50 (0.08, 0.51)0.90 (0.82, 1.00)0.59 (0.52, 0.75)
Radiomics feature model0.82 (0.72, 0.85)0.74 (0.14, 0.75)0.86 (0.85, 1.00)0.84 (0.69, 0.88)0.79 (0.54, 0.82)0.50 (0.05, 0.58)0.87 (0.68, 1.00)0.71 (0.43, 0.78)
Comprehen-sive model0.73 (0.72, 0.85)0.23 (0.19, 0.74)1.00 (0.79, 1.00)0.78 (0.70, 0.83)0.82 (0.53, 0.83)0.12 (0.05, 0.50)1.00 (0.70, 1.00)0.63 (0.42, 0.73)
95% confidence intervals are included in brackets. AUC: area under the receiver operating characteristic curve.

3.8 Prediction model through RF

The ROC curves for the RF-based ML models, including the US feature model, image feature model, and comprehensive model, are displayed in Fig. 6. In the training set, the AUC values were 0.73 (0.63, 0.74), 0.95 (0.89, 0.96) and 0.92 (0.86, 0.96), respectively, and in the testing set, they were 0.60 (0.55, 0.79), 0.65 (0.45, 0.77) and 0.76 (0.43, 0.77), respectively. Further details regarding accuracy, specificity and sensitivity are shown in Table 5.

ROC curves of each prediction model based on the RF algorithm. (A) training set; (B) testing set.

Fig. 6.ROC curves of each prediction model based on the RF algorithm. (A) training set; (B) testing set.

Table 5.Diagnostic performance of each prediction model based on RF machine learning algorithm.
Training setTesting set
Accuracy (%)Sensitivity (%)Specificity (%)AUCAccuracy (%)Sensitivity (%)Specificity (%)AUC
Ultrasound feature model0.73 (0.71, 0.81)0.32 (0.20, 0.46)0.95 (0.90, 0.99)0.73 (0.63, 0.74)0.82 (0.63, 0.85)0.50 (0.08, 0.52)0.90 (0.82, 1.00)0.60 (0.55, 0.79)
Radiomics feature model0.88 (0.81, 0.91)0.74 (0.45, 0.85)0.95 (0.87, 0.98)0.95 (0.89, 0.96)0.77 (0.54, 0.79)0.50 (0.04, 0.63)0.84 (0.64, 0.96)0.65 (0.45, 0.77)
Comprehen-sive model0.83 (0.80, 0.90)0.58 (0.44, 0.82)0.96 (0.87, 0.98)0.92 (0.86, 0.96)0.82 (0.51, 0.83)0.62 (0.12, 0.68)0.87 (0.66, 0.98)0.76 (0.43, 0.77)
95% confidence intervals are included in brackets. AUC: area under the receiver operating characteristic curve.

4. Discussion

Presently, breast cancer is the most frequently diagnosed cancer among women, comprising approximately 25% of all new cancer cases in women globally, and ranks as the second leading cause of cancer-related mortality among women [16, 17]. Among the various subtypes of breast cancer, TNBC is particularly aggressive, highlighting the importance of early diagnosis to select optimal treatment strategies. The diagnosis of TNBC primarily relies on postoperative pathological examination and immunohistochemistry. US, as a non-invasive and reproducible imaging technique, plays a valuable role in assessing women with clinical or radiological suspicions of breast lesions, aiding in the differentiation between malignant and benign lesions.

This study investigated the diagnostic potential of combining US radiomics with US features for the detection of TNBC from the images of 127 breast cancer patients, which comprised 39 cases with TNBC and 88 with non-TNBC. These patients were randomly divided into training and testing sets in a 7:3 ratio. Univariate and multivariate analyses were conducted, and the findings revealed significant differences in tumor boundary and posterior echo in the training set (p < 0.05). Subsequently, these characteristics were integrated into a multivariate LR analysis, which identified tumor margin and posterior echo as independent predictors of TNBC. However, the OR values were not substantially high.

Currently, the recognized US characteristics associated with malignant tumors include irregular shape, a non-ring edge, the presence of an echo halo, non-parallel orientation, posterior acoustic attenuation and microcalcification. However, the US presentation of TNBC remains controversial. Some studies have reported that TNBC is more likely to exhibit oval or round shapes and is often characterized by irregularity, distinguishing it from fibroadenoma [18]. Yang et al. [19] observed that TNBC masses were more inclined to display irregularity and parallel orientation rather than being circumscribed or having indistinct margins. Conversely, other research reported that TNBC may manifest as a mass with ill-defined borders or microlobulated features, and it is less likely to exhibit echo-halo boundaries compared to non-TNBC [20, 21]. Tian et al. [22] suggested that TNBC possesses its own distinct US characteristics, often presenting with a regular shape, absence of angular or spiculated edges, acoustically enhanced posterior features, steep interfaces, parallel orientation, and an absence of calcifications, similar to benign tumors, which aligns with our study findings.

Therefore, relying solely on US features may not suffice for the accurate diagnosis of TNBC. On the other hand, radiomics offers a more objective means of capturing detailed information about the lesion, which can be challenging for US practitioners to discern with the naked eye [23]. Consequently, in our study, we manually delineated the ROI in breast tumor US images. Following this, we performed feature extraction and screening using the RF method, ultimately incorporating 14 features into the radiomics model for TNBC prediction. The US radiomics feature model was established by employing four distinct ML algorithms (LR, SVM, DT and RT). Our findings indicated that the model exhibited a good fit in the training set, with moderate predictive performance. Notably, the DT method outperformed the others, while LR and SVM demonstrated greater stability.

Similarly, in a meta-analysis focused on MRI-based radiomics for TNBC diagnosis, the AUC reached 0.88, underscoring the excellent diagnostic potential of MRI-based radiomics with high specificity [24]. Qingliang Feng [25] developed a model utilizing radiomics features extracted from preoperative computed tomography (CT) scans, achieving an AUC of 0.851 through the LR method in the validation group and demonstrating the ability to differentiate between TNBC and non-TNBC, thereby providing promising potential in assisting the formulation of clinical treatment strategies. Shuai Ge [26] investigated the utilization of radiomics features derived from mammography in the preoperative prediction of TNBC, and the AUC for the testing set in their study was 0.809 (95% CI 0.711–0.907), confirming the significant value of mammography-based radiomics features in the preoperative prediction of TNBC.

In this present study, we also used the same methodology to construct both the US feature model and the comprehensive model that incorporated ultrasound and imaging features, which enabled us to further assess the utility of US radiomics in predicting TNBC. The results indicated that the diagnostic predictive performance of the US feature model in isolation was suboptimal. Conversely, the comprehensive model, constructed using the RF algorithm, exhibited superior predictive capabilities for TNBC. Furthermore, across all models, both in the training and testing sets, we noted high specificity, which highlights that radiomics features possess robust ability to differentiate non-TNBC patients, a consistent finding also observed in MRI radiomics features [24].

The selection of an appropriate ML algorithm is an important determinant for successful image-based research. Researchers should be conscious of the strengths and limitations of various ML methods and choose the most suitable one for their specific requirements to ensure obtaining reliable results that can be effectively interpreted [27]. However, due to the disparities in image acquisition, reconstruction, segmentation, and omics processing, in addition to the need for meticulous attention to data preprocessing and parameter adjustments in many image-omics applications, most clinical predictions currently operate at a feasibility level. When developing a predictive model or classifier, it is important to train it with a sufficiently representative dataset and validate it on an independent cohort to enhance result accuracy.

Our study had certain limitations. First, it was retrospective, and prospective studies are warranted to expand the model’s applicability. Second, we only constructed a diagnostic model based on conventional two-dimensional grey-scale US images without incorporating US image information from different modalities, such as US elastography and clinical patient data, including age and menstrual status. Future investigations will aim to integrate diverse information sources to optimize the model’s diagnostic capabilities. Third, compared to other studies, our feature extraction in this study may be considered limited. Thus, subsequent research efforts should place increased emphasis on radiomics feature extraction.

5. Conclusions

Compared to both the ultrasonic characteristic model and the ultrasonic imaging radiomics model, the comprehensive model demonstrated superior diagnostic performance and a more effective ability in identifying TNBC.

Availability of data and materials

The data is available from the corresponding author upon reasonable request.

Author contributions

QHD—conceived this project. DL—collected and analyzed the data. QHD and DL—wrote the manuscript. All authors read and approved the final manuscript.

Ethics approval and consent to participate

This retrospective study was approved by the Institutional Review Board and the Ethics Committee of the Affiliated Tumor Hospital of Guizhou Medical University (FZ 2022-07-217), and the requirement for informed consent was waived.

Acknowledgment

We thank the patients whose data were used.

Funding

This research received no external funding.

Conflict of interest

The authors declare no conflict of interest.

Supplementary material

Supplementary material associated with this article can be found, in the online version, at https://oss.ejgo.net/files/article/1912045325488406528/attachment/Supplementary%20material.docx.

References

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2021; 71: 209–249.

[Google Scholar]

Ma M, Liu R, Wen C, Xu W, Xu Z, Wang S, et al. Predicting the molecular subtype of breast cancer and identifying interpretable imaging features using machine learning algorithms. European Radiology. 2022; 32: 1652–1662.

[Google Scholar]

Li Y, Zhang H, Merkher Y, Chen L, Liu N, Leonov S, et al. Recent advances in therapeutic strategies for triple-negative breast cancer. Journal of Hematology & Oncology. 2022; 15: 121.

[Google Scholar]

Derakhshan F, Reis-Filho JS. Pathogenesis of triple-negative breast cancer. Annual Review of Pathology: Mechanisms of Disease. 2022; 17: 181–204.

[Google Scholar]

Freitas AJA, Causin RL, Varuzza MB, Calfa S, Hidalgo Filho CMT, Komoto TT, et al. Liquid biopsy as a tool for the diagnosis, treatment, and monitoring of breast cancer. International Journal of Molecular Sciences. 2022; 23: 9952.

[Google Scholar]

Gao Y, Luo Y, Zhao C, Xiao M, Ma L, Li W, et al. Nomogram based on radiomics analysis of primary breast cancer ultrasound images: prediction of axillary lymph node tumor burden in patients. European Radiology. 2021; 31: 928–937.

[Google Scholar]

Zhang X, Zhang Y, Zhang G, Qiu X, Tan W, Yin X, et al. Deep learning with radiomics for disease diagnosis and treatment: challenges and potential. Frontiers in Oncology. 2022; 12: 773840.

[Google Scholar]

Greener JG, Kandathil SM, Moffat L, Jones DT. A guide to machine learning for biologists. Nature Reviews Molecular Cell Biology. 2022; 23: 40–55.

[Google Scholar]

Arfat Y, Mittone G, Esposito R, Cantalupo B, De Ferrari Gm, Aldinucci M. Machine learning for cardiology. Minerva Cardiology and Angiology. 2022; 70: 75–91.

[Google Scholar]

Wagner MW, Namdar K, Biswas A, Monah S, Khalvati F, Ertl-Wagner BB. Radiomics, machine learning, and artificial intelligence—what the neuroradiologist needs to know. Neuroradiology. 2021; 63: 1957–1967.

[Google Scholar]

Gong X, Wang L, Miao L, Chen N, Li J. PIMedSeg: progressive interactive medical image segmentation. Computer Methods and Programs in Biomedicine. 2023; 241: 107776.

[Google Scholar]

van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Research. 2017; 77: e104–e107.

[Google Scholar]

Stoltzfus JC. Logistic regression: a brief primer. Academic Emergency Medicine. 2011; 18: 1099–1104.

[Google Scholar]

Flayer CH, Perner C, Sokol CL. A decision tree model for neuroimmune guidance of allergic immunity. Immunology & Cell Biology. 2021; 99: 936–948.

[Google Scholar]

Rigatti SJ. Random Forest. Journal of Insurance Medicine. 2017; 47: 31–39.

[Google Scholar]

Katsura C, Ogunmwonyi I, Kankam HK, Saha S. Breast cancer: presentation, investigation and management. British Journal of Hospital Medicine. 2022; 83: 1–7.

[Google Scholar]

Kawiak A. Molecular research and treatment of breast cancer. International Journal of Molecular Sciences. 2022; 23: 9617.

[Google Scholar]

Wojcinski S, Soliman AA, Schmidt J, Makowski L, Degenhardt F, Hillemanns P. Sonographic features of triple-negative and non-triple-negative breast cancer. Journal of Ultrasound in Medicine. 2012; 31: 1531–1541.

[Google Scholar]

Yang Q, Liu H, Liu D, Song Y. Ultrasonographic features of triple-negative breast cancer: a comparison with other breast cancer subtypes. Asian Pacific Journal of Cancer Prevention. 2015; 16: 3229–3232.

[Google Scholar]

Li Z, Tian J, Wang X, Wang Y, Wang Z, Zhang L, et al. Differences in multi-modal ultrasound imaging between triple negative and non-triple negative breast cancer. Ultrasound in Medicine & Biology. 2016; 42: 882–890.

[Google Scholar]

Wang D, Zhu K, Tian J, Li Z, Du G, Guo Q, et al. Clinicopathological and ultrasonic features of triple-negative breast cancers: a comparison with hormone receptor-positive/human epidermal growth factor receptor-2-negative breast cancers. Ultrasound in Medicine & Biology. 2018; 44: 1124–1132.

[Google Scholar]

Tian L, Wang L, Qin Y, Cai J. Systematic review and meta-analysis of the malignant ultrasound features of triple-negative breast cancer. Journal of Ultrasound in Medicine. 2020; 39: 2013–2025.

[Google Scholar]

Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016; 278: 563–577.

[Google Scholar]

Sha YS, Chen JF. MRI-based radiomics for the diagnosis of triple-negative breast cancer: a meta-analysis. Clinical Radiology. 2022; 77: 655–663.

[Google Scholar]

Feng Q, Hu Q, Liu Y, Yang T, Yin Z. Diagnosis of triple negative breast cancer based on radiomics signatures extracted from preoperative contrast-enhanced chest computed tomography. BMC Cancer. 2020; 20: 579.

[Google Scholar]

Ge S, Yixing Y, Jia D, Ling Y. Application of mammography-based radiomics signature for preoperative prediction of triple-negative breast cancer. BMC Medical Imaging. 2022; 22: 166.

[Google Scholar]

Galal A, Talal M, Moustafa A. Applications of machine learning in metabolomics: disease modeling and classification. Frontiers in Genetics. 2022; 13: 1017340.

[Google Scholar]